UCA1 and central nervous system cancer: qRT-PCR assay was conducted to assess UCA1 expression levels in normal brain tissues (NBTs), low-grade glioma tissues (grade I–II), high-grade glioma tissues (grade III–IV), as well as in NHAs and U87 and U251 glioma cells.